Podcast

Dr. Krambeck investigates efficacy of Trilogy and ShockPulse-SE lithotripters

“You have tradeoffs with every device that you use,” says Amy E. Krambeck, MD.

In this episode, Urology Times® Managing Editor Ben Saylor spoke with Amy E. Krambeck, MD. She discusses the recent Journal of Endourology study, "Multi-institutional prospective randomized control trial of novel intracorporeal lithotripters: ShockPulse-SE vs Trilogy trial," for which she served as senior author. Krambeck is a professor of urology at Northwestern University Feinberg School of Medicine in Chicago, Illinois.

Related Videos
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
Jared S. Winoker, MD, answers a question during a Zoom video interview
Human kidney stones | Image Credit: © freshidea - stock.adobe.com
Sarah Razavi, MD, answers a question during a Zoom video interview
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
John Michael DiBianco, MD, answers a question during a Zoom video interview
© 2025 MJH Life Sciences

All rights reserved.